Lev Gorfinkel, MD
Attending Physician, Cancer and Blood Disorders Center
Instructor, Harvard Medical School
Image
Lev Gorfinkel, MD
Attending Physician, Cancer and Blood Disorders Center
Instructor, Harvard Medical School
Medical Services
Languages
English
Education
Medical School
University of Massachusetts Medical School
Worcester
MA
Residency
Pediatrics
Yale University
New Haven
CT
Fellowship
Pediatric Hematology/Oncology
Boston Children's Hospital/ Dana-Farber Cancer Institute
Boston
MA
Certifications
American Board of Pediatrics (General)
Publications
ANKRD26-related Thrombocytopenia 2 with a Baseline Increase in Blasts: Implications for Clinical Surveillance. View Abstract
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation. View Abstract
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation. View Abstract
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia mice. View Abstract
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD. View Abstract
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. View Abstract
Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis. View Abstract
Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis. View Abstract
Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies. View Abstract
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. View Abstract
Transient neonatal hemolytic anemia due to the novel gamma globin gene mutation HBG2:C.290T>C, p.Leu97Pro (hemoglobin Wareham). View Abstract
Clinical decision rule for obtaining peripheral blood cultures in febrile oncology patients. View Abstract
Bone marrow transplant using fludarabine-based reduced intensity conditioning regimen with in vivo T cell depletion in patients with Fanconi anemia. View Abstract
Locations